Intended laboratory context
Illustrative applications
- Analytical comparison
- Method development
- In-vitro laboratory investigation
- Research protocol development
Lyophilized Peptides
CJC-1295 (no DAC) 10MG
Modified GRF (1–29); CJC-1295-no DAC; GHRH (1–29)-NH2
A synthetic 29-residue growth hormone-releasing hormone derivative that does not contain a drug-affinity-complex moiety.
CatalogCJCND-PW-10MG
ManufacturerRemetide
PurityProposed ≥99% by RP-HPLC; lot result controls
Pack10 mg
$115.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
630 in stock
For laboratory research use only. Not for human or veterinary use.
CJC-1295 (no DAC) 10MG$115.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Technical information
Chemical & material record
Presented in a scientific-catalog format so the material can be evaluated by identity, form and documentation before purchase.
- Identity
- CJC-1295 no DAC research peptide; salt form controlled by the approved specification
- Synonyms
- Modified GRF (1–29); CJC-1295-no DAC; GHRH (1–29)-NH2
- CAS number
- See approved salt-form specification
- Molecular formula
- See approved Remetide material specification
- Formula weight
- See approved Remetide material specification
- Sequence / identity note
- Sequence disclosed in the controlled technical record
- Manufacturer
- Remetide
- Manufacturing role
- Custom peptide synthesis and manufacture
- Form
- Lyophilized, non-sterile research material
- Purity specification
- Proposed ≥99% by RP-HPLC; lot result controls
- Storage
- -20°C, dry and protected from light; follow lot documentation
- Pack size
- 10 mg
- Catalog number
- CJCND-PW-10MG
Product description
Published context, clearly separated from lot claims.
A technical catalog should make the chemical record, relevant experimental literature and product-specific documentation independently reviewable.
CJC-1295 no DAC is a modified GHRH(1–29) peptide derivative. Unlike the DAC-conjugated form, this identity contains no drug-affinity-complex moiety; the distinction materially affects molecular identity and the interpretation of published disposition data.
Published research reported concentration-dependent growth-hormone secretion in primary rat anterior pituitary cells across picomolar-to-micromolar test ranges. The referenced assay observations are supplied as literature context only.
Selected published findings
- Characterized as a synthetic GHRH derivative in published and patent literature.
- Induced growth-hormone secretion in primary rat anterior pituitary-cell assays.
- Differs structurally from CJC-1295-DAC because it lacks the DAC moiety.
References and product citations 2
- Bridon, D.P., Boudjellab, N., Leger, R., et al. Long-lasting growth hormone-releasing factor derivatives. WO 02/062844 A2 (2002).
- Teichman, S.L., Neale, A., Lawrence, B., et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism 91(3), 799–805 (2006).
Literature interpretation: This summary describes published experimental literature and is not a lot specification, clinical claim, use instruction or representation that the supplied research material will reproduce a published result. This record intentionally excludes dosing, administration, clinical outcomes, patient eligibility and therapeutic comparisons.
Proposed package
Documentation
- PDFCertificate of AnalysisSample
- PDFHPLC chromatogramSample
- PDFMass-spectrometry summarySample
- PDFHandling statementSample
For laboratory research workflows only. Not for administration to humans or animals and not supplied with dosing or reconstitution guidance.
Need a current record?
Documentation before decision-making.
Reference CJCND-PW-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model